Literature DB >> 24919966

Reply: Retinopathy, histidine-rich protein-2 and perfusion pressure in cerebral malaria.

Ian J C MacCormick1, Nicholas A V Beare2, Terrie E Taylor3, Valentina Barrera4, Valerie A White5, Paul Hiscott4, Malcolm E Molyneux6, Baljean Dhillon7, Simon P Harding2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24919966      PMCID: PMC4132643          DOI: 10.1093/brain/awu146

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


× No keyword cloud information.
Sir, We thank Kariuki and Newton for their letter which raises several interesting points. We value their contributions to this discussion. Failure of cerebral autoregulation may be an important step in the cerebral malaria disease process. Ideally our review would have not only included comparisons of autoregulatory function in retinal and cerebral vessels, but also other important subjects such as the nature of the blood-tissue barriers, distribution of endothelial receptors, and vessel ultrastructure in retina and brain. Comparing and contrasting the retina with other areas of the CNS in terms of these and other features could well provide valuable insights, not just into cerebral malaria, but for a whole range of neurovascular diseases. We hope our paper will help to stimulate individual reviews on these topics. The utility of Plasmodium falciparum histidine-rich protein 2 (pfHRP2) as a biomarker in severe malaria has recently been reviewed (Manning and Davis, 2013). In African children with severe malaria, high pfHRP2 has been associated with anaemia, coma and death (Hendriksen ), and distinguishes presence/absence of cerebral sequestration or malarial retinopathy in separate derivation and validation cohorts (Seydel ). pfHRP2 shows clear promise as an important indicator of P. falciparum pathogenesis, and further evaluation as a biomarker of disease severity seems warranted. However, as with any prospective biomarker, evaluation must consider the biological context (Buyse ). For example, some strains of P. falciparum do not produce pfHRP2 (Gamboa ). Estimates of total body parasite load may provide useful information at a population level, but subject level variance in important biological parameters leads to improbable values for individual patients (Hendriksen ). Biological context is equally important when considering retinal features as potential markers of cerebral damage. This concern motivated our review. The available evidence suggests that malarial retinopathy, in the context of clinically defined paediatric cerebral malaria (Newton ), does indeed reflect similar disease processes in the brain. Although empirical associations between retinopathy and cerebral histopathology necessarily come from limited populations, similarities between retina and brain in terms of anatomy and physiology imply that these associations are also likely to exist more broadly. This biological context suggests inference of several distinct pathological processes from the retina to the brain is plausible, including sequestration, haemorrhage, blood-tissue barrier breakdown, and ischaemia (MacCormick ). Consequently, retinal imaging in severe malaria has the potential to provide information on a range of interdependent pathological processes, taking place within the CNS. In the same way that parasite detection by microscopy depends on an experienced technician, accurate detection of malarial retinopathy depends on the observer and the method. There is a need for a standardized approach to malarial retinopathy. This will facilitate accurate comparisons between studies, and help to define the characteristics and clinical associations of both malarial retinopathy and cerebral malaria more generally. Progressive technological advances in retinal imaging are likely to increase the utility of retinal observations. Far from precluding the use of other disease markers, retinal imaging represents an opportunity to assess novel biomarkers, both for their clinical use and to investigate relationships between multiple aspects of cerebral pathogenesis. More work is needed to compare retina–brain biological characteristics, describe empirical associations between retina, brain, and prospective biomarkers (including pfHRP2), and to standardize imaging methodology in malaria research.
  7 in total

Review 1.  Biomarkers and surrogate end points--the challenge of statistical validation.

Authors:  Marc Buyse; Daniel J Sargent; Axel Grothey; Alastair Matheson; Aimery de Gramont
Journal:  Nat Rev Clin Oncol       Date:  2010-04-06       Impact factor: 66.675

Review 2.  Pathophysiology of fatal falciparum malaria in African children.

Authors:  C R Newton; T E Taylor; R O Whitten
Journal:  Am J Trop Med Hyg       Date:  1998-05       Impact factor: 2.345

3.  A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests.

Authors:  Dionicia Gamboa; Mei-Fong Ho; Jorge Bendezu; Katherine Torres; Peter L Chiodini; John W Barnwell; Sandra Incardona; Mark Perkins; David Bell; James McCarthy; Qin Cheng
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

Review 4.  The mechanistic, diagnostic and prognostic utility of biomarkers in severe malaria.

Authors:  Laurens Manning; Timothy Mark Earls Davis
Journal:  Biomark Med       Date:  2013-06       Impact factor: 2.851

5.  Plasma concentrations of parasite histidine-rich protein 2 distinguish between retinopathy-positive and retinopathy-negative cerebral malaria in Malawian children.

Authors:  Karl B Seydel; Lindsay L Fox; Simon J Glover; Mathew J Reeves; Paul Pensulo; Alice Muiruri; Ashley Mpakiza; Malcolm E Molyneux; Terrie E Taylor
Journal:  J Infect Dis       Date:  2012-05-25       Impact factor: 7.759

6.  Diagnosing severe falciparum malaria in parasitaemic African children: a prospective evaluation of plasma PfHRP2 measurement.

Authors:  Ilse C E Hendriksen; Juliet Mwanga-Amumpaire; Lorenz von Seidlein; George Mtove; Lisa J White; Rasaq Olaosebikan; Sue J Lee; Antoinette K Tshefu; Charles Woodrow; Ben Amos; Corine Karema; Somporn Saiwaew; Kathryn Maitland; Ermelinda Gomes; Wirichada Pan-Ngum; Samwel Gesase; Kamolrat Silamut; Hugh Reyburn; Sarah Joseph; Kesinee Chotivanich; Caterina I Fanello; Nicholas P J Day; Nicholas J White; Arjen M Dondorp
Journal:  PLoS Med       Date:  2012-08-21       Impact factor: 11.069

Review 7.  Cerebral malaria in children: using the retina to study the brain.

Authors:  Ian J C MacCormick; Nicholas A V Beare; Terrie E Taylor; Valentina Barrera; Valerie A White; Paul Hiscott; Malcolm E Molyneux; Baljean Dhillon; Simon P Harding
Journal:  Brain       Date:  2014-02-26       Impact factor: 13.501

  7 in total
  1 in total

1.  Clinical trials to assess adjuvant therapeutics for severe malaria.

Authors:  Rosauro Varo; Clara Erice; Sydney Johnson; Quique Bassat; Kevin C Kain
Journal:  Malar J       Date:  2020-07-24       Impact factor: 2.979

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.